Nonalcoholic Fatty Liver Disease and Weight Loss / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
; (6): 597-602, 2018.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-690289
Biblioteca responsável:
WPRO
ABSTRACT
Nonalcoholic fatty liver disease(NAFLD)refers to hepatic steatosis without other known causes such as alcohol abuse or hepatic virus infection. NAFLD has become a chronic disease worldwide,and its prevalence is constantly growing. Hepatic insulin resistance caused by obesity results in the deposition of triglycerides in the liver,promoting the occurrence and development of NAFLD. Weight loss is the only safe and effective method for NAFLD. Lifestyle intervention plays a cornerstone role in treating NAFLD;however,most patients can not achieve and maintain the ideal body weight by lifestyle intervention alone. Glucagon-like peptide-1 receptor agonist and metabolic surgery are promising treatments for NAFLD.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Aspecto:
Preferência do paciente
Idioma:
Chinês
Revista:
Acta Academiae Medicinae Sinicae
Ano de publicação:
2018
Tipo de documento:
Artigo